Trial Profile
Udenafil Therapy to Improve Symptomatology, Exercise Tolerance and Hemodynamics in Patients With Mild Pulmonary Hypertension [ULTIMATE-Mild PHT]
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Udenafil (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- Acronyms ULTIMATE-Mild PHT
- 26 Aug 2014 New trial record